Skip to content

Microfoam Sclerotherapy for Venous Malformations

Microfoam Sclerotherapy for Venous Malformations, Phase I/II Prospective Study

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1061230050
Enrollment
12
Registered
2023-08-18
Start date
2023-08-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

venous malformation venous malformation, sclerotherapy, microfoam

Interventions

sclerotherapy for venous malformations using microfoam
D035703
venous malformation sclerotherapy microfoam

Sponsors

Hiroyasu Fujiwara
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Written informed consent was obtained from patient or protector

Exclusion criteria

Exclusion criteria: Facial lesions

Design outcomes

Primary

MeasureTime frame
safety

Secondary

MeasureTime frame
efficacy

Contacts

Public ContactFujiwara Hiroyasu

Kawasaki Medical School General Medical Center

hirofujiwar@gmail.com+81-862252111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026